Lack of sustained hemodynamic effects of the beta 2-adrenoceptor agonist dopexamine in end-stage congestive heart failure.

Source:http://linkedlifedata.com/resource/pubmed/id/1967897

Am. J. Cardiol. 1990 Feb 1 65 5 395-6

Download in:

View as

General Info

PMID
1967897